https://regulatorynews.com/microbiotica-mb310-series-c-financing Regulatory News en 2026-10-19T09:46:44-04:00 Microbiotica Raises £36M to Push MB310 to Phase 2 https://regulatorynews.com/fda-counterfeit-eye-drops-several-states Regulatory News en 2026-10-19T05:57:28-04:00 FDA Flags Counterfeit Eye Drops in Several States https://regulatorynews.com/fda-rare-disease-framework-initiative Regulatory News en 2026-10-19T05:57:28-04:00 FDA Launches Rare Disease Drug Review Framework https://regulatorynews.com/immunitybio-anktiva-papillary-nmibc-expansion Regulatory News en 2026-10-19T05:57:28-04:00 FDA Expands Anktiva to Papillary-Only Bladder Cancer https://regulatorynews.com/omass-therapeutics-series-c-financing Regulatory News en 2026-10-18T09:34:20-04:00 OMass Therapeutics Raises $310M Series C https://regulatorynews.com/opus-genetics-ryzumvi-presbyopia-approval Regulatory News en 2026-10-18T09:34:20-04:00 Opus Genetics Wins Second FDA Nod for RYZUMVI https://regulatorynews.com/simbiosys-tumorsight-risk-fda-clearance Regulatory News en 2026-10-18T09:34:20-04:00 SimBioSys Earns FDA Clearance for TumorSight Risk https://regulatorynews.com/alcon-brytly-apraclonidine-otc-approval Regulatory News en 2026-10-18T05:55:27-04:00 FDA Clears First OTC Apraclonidine Drop, Alcon's Brytly https://regulatorynews.com/fda-ectd-validation-rejection-january-2027 Regulatory News en 2026-10-18T05:55:27-04:00 FDA Sets Jan. 2027 Cutoff to Reject Bad eCTD Submissions https://regulatorynews.com/mhra-antidepressant-boxed-warning-review Regulatory News en 2026-10-18T05:55:27-04:00 MHRA Orders Boxed Suicide-Risk Warning on Antidepressants